Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,18344,71,1.91 [1.35-2.68],0.0002116662955099
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,18567,71,13.34 [5.63-31.60],3.877133794828786e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,15956,64,3.20 [1.76-5.81],0.0001384788163701
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,18492,70,3.98 [2.15-7.36],1.0921842038447618e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,18572,71,2.90 [2.05-4.11],2.2468739483169957e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,15560,59,4.56 [3.16-6.58],5.365531643133178e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,18663,72,10.17 [4.04-25.63],8.619623672826231e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,15336,58,1.89 [1.55-2.29],1.6466948757496175e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,18344,71,1.95 [1.46-2.59],4.896092737505665e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,18555,70,2.94 [2.37-3.65],1.3449875722897561e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,18014,68,1.90 [1.52-2.38],1.94575533579984e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,18039,70,2.04 [1.64-2.53],1.8181905638829016e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,15956,64,2.13 [1.49-3.03],2.889340574241879e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,16032,63,1.69 [1.25-2.29],0.0006665950688287
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",18492,70,12.54 [7.50-20.97],5.152099419985515e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,15528,61,2.03 [1.46-2.83],2.8851718543464063e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,15980,64,1.92 [1.67-2.20],1.3450014215564091e-20
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,15956,64,2.53 [2.15-2.97],1.289229127561338e-29
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,15528,61,3.48 [2.94-4.10],5.544448011559757e-49
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,15528,61,3.06 [2.22-4.21],6.930347308297421e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,18597,71,1.71 [1.25-2.35],0.0008894872487909
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,18492,70,4.02 [2.14-7.56],1.558795467338003e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,18427,71,2.10 [1.37-3.22],0.0006330338305859
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,15997,63,7.84 [2.33-26.39],0.0008755530253769
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,15980,64,3.27 [2.60-4.10],2.287492947519362e-24
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,18369,70,19.40 [7.42-50.71],1.4542729701687543e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,18320,70,1.80 [1.34-2.42],8.297215696145679e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,15987,64,1.68 [1.43-1.97],3.633429720032063e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,18427,71,1.60 [1.38-1.85],3.262106066475151e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,15731,62,3.44 [1.69-6.98],0.0006417215465837
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,18427,71,4.95 [3.98-6.14],2.6602143002628653e-47
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,18653,71,3.79 [3.01-4.76],3.1342275574121703e-30
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,18477,72,7.05 [5.21-9.52],5.390237159785394e-37
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,18014,68,2.38 [1.84-3.07],3.031647528605997e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,18352,68,3.38 [1.99-5.71],5.851482143820566e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,18471,70,20.23 [13.49-30.34],5.928745916623256e-48
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,18580,70,4.96 [4.16-5.92],2.000473217231505e-70
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,15963,62,0.40 [0.24-0.68],0.0006961360177797
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,18620,71,5.60 [3.98-7.88],5.808791068616979e-23
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,18427,71,5.70 [4.53-7.17],5.126821329636285e-50
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,15659,64,7.74 [5.90-10.17],4.535583433443921e-49
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,18597,71,10.70 [7.32-15.64],2.161029121393215e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,18653,71,6.35 [5.18-7.79],1.646843146246969e-70
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,16007,62,7.68 [5.44-10.85],5.69947617209877e-31
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,18427,71,5.97 [3.74-9.54],8.127691696299649e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,15956,64,4.22 [2.31-7.74],3.0466823600601253e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,18597,71,1.85 [1.33-2.59],0.0002885975994763
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,18597,71,3.58 [2.21-5.81],2.395469617900915e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,15659,64,0.41 [0.25-0.67],0.0003165205876647
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",15980,64,2.62 [2.00-3.45],4.103807820646019e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,18562,71,3.46 [2.55-4.68],9.891409404142223e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,15528,61,4.16 [2.68-6.47],2.2054360888742158e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,18427,71,2.91 [2.05-4.13],2.1429405609701754e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,15980,64,4.16 [2.65-6.52],5.144209748852256e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,16007,62,3.51 [2.38-5.17],2.0743647935477384e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,15731,62,1.84 [1.44-2.36],1.4275645663278277e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,15972,63,3.46 [1.90-6.32],5.238228556933279e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,18520,69,3.31 [2.24-4.89],1.7280881808983975e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,17988,68,1.95 [1.56-2.43],4.1186510624004755e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,18492,70,7.32 [3.24-16.55],1.724007642037617e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,18284,71,4.51 [3.18-6.39],2.239994398991996e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,18492,70,5.41 [2.78-10.53],6.713668960905128e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,16029,64,2.23 [1.50-3.32],7.100209021730193e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,18432,70,4.15 [1.97-8.71],0.0001733763199983
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,15864,63,2.11 [1.77-2.51],2.6933971890506402e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,18597,71,1.52 [1.27-1.82],5.95122908657249e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,15792,64,3.43 [2.70-4.35],4.110714276100687e-24
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,18432,70,5.16 [3.11-8.56],2.18388679696374e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,15485,61,1.98 [1.36-2.88],0.0003824984651675
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,18597,71,7.06 [3.54-14.05],2.6749510719268444e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,18014,68,1.60 [1.27-2.01],7.702463690209747e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,18653,71,1.74 [1.32-2.29],9.003834602266798e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,15951,63,2.32 [1.83-2.93],3.270816730709641e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,18344,71,1.73 [1.26-2.39],0.0007950892804256
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,15560,59,1.83 [1.31-2.56],0.0004457500952726
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,18284,71,2.15 [1.68-2.75],1.649490742759635e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,18344,71,5.02 [3.08-8.17],9.090514533566212e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,18555,70,1.87 [1.48-2.36],1.738433422487811e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,15987,64,3.02 [1.64-5.58],0.0004163726822078
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,18344,71,7.04 [4.53-10.94],3.7380146972071385e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,15980,64,2.29 [1.45-3.62],0.0003622917901182
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,18583,70,3.49 [1.85-6.57],0.0001132469040516
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,18400,69,2.82 [1.53-5.19],0.0008950023432088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,18250,71,9.41 [6.99-12.67],2.1472761662590146e-49
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,18427,71,1.90 [1.65-2.20],1.607615006600753e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,18344,71,2.25 [1.99-2.56],1.3027646089953896e-36
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,18663,72,6.37 [2.47-16.41],0.000124857961596
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,15485,61,3.64 [2.44-5.44],2.4228764359884776e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,18663,72,4.08 [1.91-8.74],0.0002938236727922
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,15560,59,1.96 [1.49-2.58],1.4228699695480098e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,17790,69,3.58 [2.16-5.94],7.718318180700733e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,15659,64,4.57 [2.05-10.17],0.0001955424917545
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,18256,71,4.47 [2.55-7.82],1.6391629933616945e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,18427,71,1.53 [1.26-1.87],2.1102343549644057e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,18578,70,5.71 [3.81-8.56],3.425108432197204e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,15731,62,3.55 [2.69-4.69],4.6487569052595695e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,18597,71,6.73 [4.62-9.81],2.933980458920329e-23
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,16007,62,2.02 [1.48-2.75],7.721772684889052e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,18432,70,3.66 [3.28-4.09],3.2690046693060525e-116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,18014,68,1.71 [1.29-2.26],0.0001694375905451
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,18432,70,3.36 [2.75-4.10],8.096191424632299e-33
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,18569,71,3.66 [3.16-4.24],1.0081244649909783e-67
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,18124,68,3.95 [3.31-4.70],1.4554728566499972e-53
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,18432,70,4.93 [3.72-6.55],1.8861470190351447e-28
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,18014,68,1.51 [1.20-1.90],0.0004134006269553
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,18014,68,1.58 [1.36-1.82],6.365796423060042e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,18427,71,2.02 [1.58-2.59],2.1866096938109453e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,15528,61,2.00 [1.42-2.81],7.439376885762322e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,18427,71,1.68 [1.33-2.12],1.0773903550999554e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,17984,68,3.98 [3.10-5.11],3.3185369129501386e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,18124,68,3.23 [2.39-4.37],2.3946870477208887e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,18344,71,12.66 [4.99-32.09],8.840384483599198e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,15952,64,1.71 [1.26-2.32],0.0006326140347964
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,15282,61,2.04 [1.56-2.65],1.3326133158357013e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,18583,70,3.47 [1.84-6.55],0.0001208888237452
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,18014,68,0.66 [0.53-0.82],0.0002121026135205
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,15980,64,2.72 [1.53-4.84],0.0006794603728694
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,15951,63,1.91 [1.54-2.38],5.7287322772877366e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,18039,70,2.32 [1.74-3.09],8.764481981054419e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,18332,69,9.30 [6.50-13.30],2.6252932094855047e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,18653,71,2.69 [1.75-4.14],6.378035855734826e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,18109,70,1.37 [1.16-1.63],0.0002601536163788
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,18432,70,2.79 [1.71-4.55],3.7760863750540416e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,18557,70,0.60 [0.45-0.80],0.0004793814604255
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,15980,64,2.42 [1.97-2.97],3.682138930066411e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",18427,71,3.09 [1.81-5.27],3.597081282496369e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,18039,70,2.08 [1.66-2.61],1.8277396064729358e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,15987,64,2.02 [1.64-2.49],2.6983924015486947e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,18663,72,4.39 [1.86-10.39],0.0007554806073558
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,18374,68,4.04 [2.20-7.41],6.631651041496177e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,18663,72,22.24 [15.61-31.67],3.0526670423003124e-66
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,18344,71,10.46 [3.57-30.64],1.836834165648631e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,15594,64,3.98 [2.64-5.99],3.971678750640568e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,18492,70,3.18 [1.85-5.48],3.080085093674548e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,18427,71,2.78 [2.19-3.54],8.761341755561712e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,18432,70,6.47 [2.97-14.13],2.7570944269724338e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,18344,71,4.82 [4.05-5.75],1.5415928470991078e-69
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,18124,68,1.55 [1.31-1.83],3.2359405503679865e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,18492,70,2.56 [1.72-3.81],3.954691203249269e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,18344,71,1.79 [1.41-2.28],2.400357376558175e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,18653,71,2.28 [1.58-3.28],1.0782338345492104e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,18124,68,3.65 [2.53-5.28],5.95924785889668e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,18124,68,4.52 [2.67-7.67],2.031504687668372e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,18653,71,2.63 [2.06-3.36],1.0583102142715344e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,18520,69,5.65 [3.44-9.28],8.227318751013179e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,18317,71,4.51 [3.51-5.79],6.241724427176763e-32
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,15951,63,2.27 [1.68-3.08],1.2246491806513329e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,18427,71,4.82 [3.52-6.61],1.3463182379242758e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,18427,71,0.37 [0.25-0.55],6.805316356042561e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,18427,71,0.52 [0.37-0.73],0.0002141381641812
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,18007,69,1.77 [1.46-2.14],6.464963829193295e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,18011,70,2.18 [1.84-2.58],1.3527241768798422e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",15560,59,3.44 [2.48-4.78],1.4599767769083782e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",18109,70,1.64 [1.38-1.94],1.7405041783892288e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,15528,61,3.51 [1.97-6.26],2.0175531072351337e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,18124,68,1.54 [1.20-1.99],0.0008270836287661
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,15485,61,1.48 [1.18-1.85],0.000635981046963
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,15523,61,1.81 [1.28-2.57],0.0007958505250795
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,15277,62,0.31 [0.16-0.60],0.000577137035528
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,18477,72,5.48 [2.91-10.34],1.4623288260215946e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,18344,71,2.63 [2.05-3.39],5.81991677414281e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,18402,70,2.11 [1.41-3.15],0.0002976456548511
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,18256,71,2.34 [1.42-3.87],0.0009032194187339
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,18413,70,3.52 [1.97-6.29],2.2073741698428705e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,18663,72,10.90 [5.82-20.41],8.243305374595985e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,18572,71,3.37 [1.79-6.33],0.0001663515068576
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,18124,68,2.96 [1.95-4.50],3.371726646997685e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,15929,64,1.59 [1.26-2.01],7.99976562813524e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,15980,64,3.20 [1.86-5.49],2.5495675234455862e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,15485,61,1.82 [1.40-2.38],1.0689450858438412e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,16032,63,4.98 [2.24-11.04],7.912243687389236e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,15956,64,6.60 [3.99-10.92],2.078891029831017e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,18427,71,6.84 [4.93-9.49],1.4470091120168123e-30
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,15951,63,1.82 [1.29-2.57],0.000633337897688
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,18014,68,1.63 [1.26-2.10],0.0002048673164746
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,18427,71,5.49 [3.04-9.90],1.493588661211916e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,18205,71,24.58 [17.25-35.01],2.1864261146341183e-70
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,18284,71,0.31 [0.17-0.57],0.0001747935085026
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,18014,68,1.73 [1.51-1.99],1.0704622418660308e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,18337,72,2.52 [1.54-4.13],0.0002343332846047
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,18227,71,1.90 [1.60-2.27],8.049228408444399e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,18014,68,1.83 [1.32-2.54],0.0003133266430733
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",15560,59,11.79 [4.64-29.98],2.203892270329938e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,15980,64,2.27 [1.76-2.94],2.7409940909477166e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,15454,61,1.98 [1.49-2.62],2.080166939170536e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,15980,64,3.29 [2.26-4.78],4.2119389619991957e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,15987,64,1.81 [1.45-2.25],1.1417866879344209e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,15951,63,1.86 [1.41-2.45],1.1136008490326031e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,15532,59,2.23 [1.54-3.25],2.4216156878499303e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,15659,64,5.70 [2.28-14.23],0.0001918989187776
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,18124,68,2.11 [1.85-2.42],1.065312252483144e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",18427,71,1.42 [1.16-1.75],0.0007078855639139
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,15485,61,1.94 [1.42-2.65],3.577243191586477e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,18014,68,3.78 [2.89-4.94],1.625303661990104e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,15485,61,2.48 [1.98-3.12],4.2639313183913166e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,18284,71,1.83 [1.63-2.06],9.759613312485294e-24
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",18039,70,1.61 [1.23-2.10],0.0005350572433068
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,18663,72,4.13 [2.09-8.17],4.470322849068502e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,15754,61,2.73 [1.59-4.71],0.0002927328425118
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,18432,70,4.38 [2.29-8.37],8.050615330116158e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,18344,71,4.10 [2.50-6.72],2.42909966603854e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,18427,71,1.96 [1.76-2.19],1.189386140401973e-33
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,15956,64,9.46 [5.42-16.49],2.345317274272668e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,18574,70,6.40 [4.90-8.37],5.945096613405115e-42
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",18318,71,1.56 [1.22-1.99],0.0003580754710619
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,18427,71,2.94 [2.35-3.68],6.160911165748098e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,18432,70,3.82 [2.26-6.43],4.919438372508837e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,15599,60,2.06 [1.66-2.56],6.621090968239888e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,15523,61,2.10 [1.61-2.74],4.44977138683501e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,15528,61,1.85 [1.35-2.53],0.0001243149322708
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",18344,71,2.83 [2.29-3.49],3.189996113210883e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,18014,68,1.93 [1.67-2.23],1.5968983793860793e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,18014,68,2.21 [1.71-2.86],1.4998005397628623e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,15560,59,3.63 [2.15-6.13],1.4672810485890638e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,18427,71,1.99 [1.73-2.29],1.7211620978069631e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,18323,68,2.93 [1.80-4.78],1.554216787999686e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,18284,71,1.72 [1.37-2.16],2.8858101323642126e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,16018,64,14.63 [9.58-22.33],1.8186381778330472e-35
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,17945,69,1.74 [1.27-2.38],0.0005733631673807
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,18124,68,1.71 [1.26-2.33],0.0006746367187684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,15951,63,1.98 [1.56-2.52],1.5554687539350015e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,18014,68,1.62 [1.38-1.90],6.1181280973445725e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,15485,61,1.99 [1.56-2.53],2.219290311729396e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,18432,70,3.32 [1.88-5.88],3.587102588445565e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,15919,61,1.97 [1.36-2.84],0.0003123820102385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,15560,59,3.90 [2.10-7.24],1.5574567627101162e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,18432,70,4.62 [2.20-9.69],5.131669063739409e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,18432,70,7.02 [3.86-12.76],1.7008941551624095e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,15560,59,5.53 [3.52-8.69],1.2511108843584897e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,18014,68,1.64 [1.25-2.16],0.0003898427206562
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,15987,64,2.16 [1.53-3.06],1.2366868743588692e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,15485,61,2.24 [1.90-2.64],7.146666637244323e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,18344,71,1.69 [1.34-2.13],7.142255444942486e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,18432,70,0.50 [0.37-0.66],1.83694084715836e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,15659,64,4.08 [3.35-4.95],2.6312487769848905e-45
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,16032,63,10.30 [6.76-15.68],1.5942536569191218e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,18427,71,2.75 [1.52-4.96],0.0007828103908915
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,15659,64,2.06 [1.35-3.14],0.0008156128432927
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,18603,72,5.82 [4.27-7.93],6.696356949803479e-29
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,15948,64,2.36 [1.44-3.87],0.0006837757305567
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,18344,71,3.06 [2.10-4.44],5.039367769638272e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,18653,71,1.58 [1.29-1.94],9.651878880882162e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,18216,70,3.37 [2.14-5.30],1.518353603813772e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,18492,70,2.79 [1.85-4.20],8.840226551507495e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,18432,70,1.57 [1.21-2.04],0.0006933387660268
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,18606,70,8.64 [6.52-11.46],7.829402916901134e-51
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,15560,59,3.05 [1.87-5.00],9.036210745820729e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,18124,68,2.75 [1.93-3.92],2.4264673548611578e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,18014,68,4.66 [3.72-5.84],8.783286014247877e-41
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,18014,68,2.64 [1.84-3.78],1.2388730500732157e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,18606,70,2.39 [1.50-3.83],0.0002618805360162
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,15956,64,2.21 [1.94-2.52],1.4579526044783269e-33
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,15485,61,1.83 [1.51-2.21],3.664248008404077e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,18365,69,5.19 [3.12-8.62],2.161025473149068e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,15454,61,1.55 [1.22-1.96],0.0003467709985358
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",15523,61,2.54 [1.78-3.63],2.6317856482928055e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,18344,71,2.77 [2.28-3.36],5.111241523415993e-25
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,18427,71,1.49 [1.21-1.83],0.0001954942910265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",18344,71,1.76 [1.27-2.46],0.0007496678493549
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,18597,71,9.21 [7.32-11.59],8.300976688652306e-80
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,18410,70,4.93 [2.05-11.83],0.0003573422392381
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,15528,61,2.62 [1.62-4.24],8.829709837864227e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,15956,64,2.90 [2.34-3.60],3.258622798573132e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,15980,64,2.53 [1.94-3.28],4.464741416514124e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,18261,71,2.92 [2.55-3.34],6.384388373840558e-54
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,16007,62,2.87 [2.24-3.69],1.7573046103395416e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,15951,63,1.77 [1.49-2.10],6.249156002713087e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,18521,69,2.52 [1.59-3.99],8.02634188420102e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,18432,70,2.66 [1.77-4.00],2.440421341551386e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",18011,70,1.98 [1.44-2.71],2.205337943422221e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,18520,69,3.06 [2.02-4.64],1.3619091317792166e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,18432,70,1.63 [1.25-2.12],0.0003489291520231
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,18084,70,2.10 [1.65-2.67],1.4232596052426291e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,18284,71,1.55 [1.31-1.84],3.466946482580712e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,18432,70,4.35 [3.60-5.26],3.862531204197715e-52
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,18124,68,4.06 [3.44-4.79],2.040906845988937e-61
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,15659,64,4.03 [2.41-6.74],1.0298309037809184e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,18432,70,2.64 [1.49-4.68],0.0008592232029657
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,18432,70,2.00 [1.59-2.51],2.887931556959417e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,18620,71,6.02 [4.22-8.58],3.3552362113020624e-23
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,18597,71,2.84 [2.06-3.90],1.4203561009675422e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,18284,71,4.68 [4.09-5.36],1.282540922118068e-110
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,18632,72,0.45 [0.30-0.67],9.05595920053646e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,16018,64,3.71 [2.50-5.51],6.821748943269124e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,15980,64,1.62 [1.28-2.06],7.575654525572106e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,15528,61,1.99 [1.56-2.53],2.1400336084182847e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,18014,68,2.25 [1.77-2.86],2.787892943386265e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,15528,61,1.94 [1.52-2.48],9.63310967228617e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,16007,62,4.63 [2.11-10.13],0.0001259239693597
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,15485,61,1.68 [1.38-2.06],3.569211040309483e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",15528,61,2.06 [1.50-2.83],8.347512120399166e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,18432,70,9.44 [6.47-13.75],1.6406427983251878e-31
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,18284,71,2.39 [1.50-3.80],0.0002301978930305
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,18498,69,6.90 [3.75-12.68],5.112902033108282e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,15951,63,3.34 [2.11-5.27],2.560112918218885e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,15528,61,2.80 [2.16-3.63],8.927538401159256e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,15980,64,2.94 [2.50-3.46],3.84070758158628e-39
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,15956,64,1.76 [1.33-2.33],7.868652045432441e-05
